Eyeworld

EW REFRACTIVE 28 January 2017 by Liz Hillman EyeWorld Staff Writer his career, Dr. Thompson has been involved in more than 60 FDA mon- itored trials, including those for PTK, PRK, LASIK, phakic IOLs, the Light Adjustable Lens (Calhoun Vision, Pasadena, California), small incision lenticule extraction (SMILE), and Avedro's (Waltham, Massachusetts) recently approved corneal collagen crosslinking. He was also integrally involved in the research and devel- opment of femtosecond laser flaps and cataract surgery. "As a result of the joy of practice and the joy of the team and hard work in research and development, it has led to quite a bit of opportu- nity to work with the outside world, be it through consulting or writing," Dr. Thompson said. "I love to teach … I approach refractive surgery as a comprehensive refractive surgeon. I'm hoping to get across in my jour- ney with EyeWorld what the prin- ciples of refractive surgery are that need to be respected no matter what procedure it is." Some of these principles include consideration of how refractive surgery affects the patient's life both in the short and long term, meaning preservation of best corrected vision quality. Dr. Thompson would go on to complete a cataract and refractive surgery fellowship at the Hunkeler Eye Clinic, Overland Park, Kansas, with Daniel Durrie, MD, and John Hunkeler, MD, who at the time were involved with investigating phototherapeutic keratectomy (PTK) and starting the partially sighted eye PRK trial. "Being there when the exci- mer laser was beginning and being involved in those FDA trials is what led me, when I came back to my home state, to start my own refrac- tive surgery research program. It is why I was asked to be a medical monitor and investigator in the PRK and PTK trials, and it ultimately led to me being involved in the early LASIK trials in our country," he said. "That fellowship and the excimer laser changed my career path in an amazing way." Dr. Thompson opened a practice on the campus of a hospital system in Sioux Falls in 1991. After out- growing two buildings, he eventu- ally set up Vance Thompson Vision with his partners Alison Tendler, MD, John Berdahl, MD, Michael Greenwood, MD, and Matt Jensen, MBA. The practice now has a team of more than 100 people. During The surgeon from South Dakota plans to guide section with view of comprehensive refractive surgery V ance Thompson, MD, Vance Thompson Vision, Sioux Falls, South Dakota, started his position as EyeWorld's Refractive section editor in late 2016. "I cannot imagine a better person than Vance to lead refractive surgery at EyeWorld as we examine and learn about these new tech- nologies," said Eric Donnenfeld, MD, EyeWorld chief medical edi- tor, Rockville Centre, New York. EyeWorld welcomes Vance Thompson, MD, as its new Refractive section editor "Vance Thompson is the unicorn of refractive surgeons in that he just might be too good to be true. He is a superb clinician, researcher, and thought leader, as well as a wonder- ful public speaker." Dr. Thompson grew up in a small town in South Dakota, think- ing he would follow in his father's and grandfather's footsteps of being a family doctor. In medical school, however, he spent time with an ophthalmologist who, as he put it, "literally changed my career." While still in residency at the University of Missouri, Columbia, Dr. Thompson attended his first meeting of the American Academy of Ophthalmology (AAO) in 1989 in New Orleans, and it turned out to be a pivotal event. "I was hungry, and my wife and I were poor as church mice, so we went to this free breakfast. I'm enjoying the breakfast, and my wife says, 'You should listen to this; it sounds like a game chang- er.' It was Marguerite McDonald [MD] presenting at a VISX [Abbott Medical Optics, Abbott Park, Illinois] breakfast on the blind eye study that she had done with PRK. I ended up being quite moved by that," he said. Refractive editor's corner of the world Vance Thompson, MD View the EyeWorld CME and non-CME supplements at: cmesupplements. eyeworld.org supplements. eyeworld.org Supported by ..... EyeWorld December 2016 Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continu- ing Medical Education through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. Educational Objectives Ophthalmologists who participate in this activity will: • Identify different pathways and models that permit the viable integration of LACS into a refractive cataract practice: accessibility pathways, reimbursement models for technology access, and practice flow models in a variety of settings; and • Develop customized practice adoption plans for advanced technologies: protocols for staff training and proper patient conversation techniques for expectation management and accep- tance of technology. Designation Statement The American Society of Cataract and Refractive Surgery designates this enduring materials educational activity for a maximum of 1.0 AMA PRA Category 1 Credits. ™ Physicians should claim only credit commensurate with the extent of their participation in the activity. Claiming Credit To claim credit, participants must visit bit.ly/2ffsgw8 to review content and download the post-activity test and credit claim. All participants must pass the post-activity test with a score of 75% or higher to earn credit. Alternatively, the post-test form included in this monograph may be faxed to the number indicated for credit to be awarded, and a certificate will be mailed within 2 weeks. When viewing online or downloading the material, standard internet access is required. Adobe Acrobat Reader is needed to view the materials. CME credit is valid through May 31, 2017. CME credit will not be awarded after that date. Notice of Off-Label Use Presentations This activity may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. ADA/Special Accommodations ASCRS and EyeWorld fully comply with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. Any participant in this educational program who requires special accommodations or services should contact Laura Johnson at ljohnson@ascrs. org or 703-591-2220. Financial Interest Disclosures David Dillman, MD, has received a retain- er, ad hoc fees or other consulting income from Alcon Laboratories and Sightpath Medical. Gary Foster, MD, has an investment interest in AcuFocus and Alphaeon. He has received research funding from Alcon Laboratories, Bausch + Lomb, and Ivantis. Dr. Foster has received a retainer, ad hoc fees or other consulting income from and is a member of the speakers bureau of Alcon Laboratories. Steven Slade, MD, has an investment in- terest in Novartis and RVO. He has received a retainer, ad hoc fees or other consulting income from: Alcon Laboratories, Bausch + Lomb, Carl Zeiss Meditec, and Clarity Medical. Elizabeth Yeu, MD, has an investment interest in Modernizing Medicine and RPS. She has received a retainer, ad hoc fees or other consulting income from and is a member of the speakers bureau of: Abbott Medical Optics, Alcon Laboratories, Allergan, Bio-Tissue, i-Optics, Shire, and TearLab. Dr. Yeu has received a retainer, ad hoc fees or other consulting income from: ArcScan, Bausch + Lomb, Kala, Ocular Therapeutix, OcuSoft, and Omeros. She has received research funding from: Bio-Tissue, i-Optics, Kala, and Topcon. Staff members: Kristen Covington and Laura Johnson have no ophthalmic-related financial interests. Methods for making laser-assisted cataract surgery fit in your practice Laser-assisted cataract surgery (LACS) 365 Curriculum continued on page 2 by Stephen Slade, MD Financing femto: Breaking even with direct acquisition permanence and commitment to patients. Although we initially began using the femtosecond laser during our investigational work, we did not know how often we would use it in our practice. Ulti- mately, our patient volume grew significantly. I consider femtosec- ond laser-assisted cataract surgery to be an excellent practice builder. femtosecond laser for our ambu- latory surgery center. With this option, the laser would be more available, making procedures more convenient and accessible for our patients. Because we own our laser, we can perform femto- second procedures at any time, without relying on someone else's schedule. This offers us greater independence. I also think that owning our laser indicates our Surgeon details points to consider before purchasing femto laser A s laser and lens technology advances, more cataract surgeons are considering the jump to femtosecond laser-assisted cataract surgery. For a number of reasons, pur- chasing a femtosecond laser was the right choice for our practice, but each surgeon needs to take a look at his or her own practice to establish whether this is a viable option. This article shares the process we used when analyzing this investment. Practical advantages Rather than sharing laser access or using a mobile equipment service, we chose to purchase a Practice pearl: Do your homework to ensure financial success with a femtosecond laser for cataract surgery. A simple pro forma including your number of cases, direct expenses, etc., will go a long way in guiding your decision. Also take a careful look at your available space options and needs for the laser. –Stephen Slade, MD " By developing the pro forma, we knew what to expect as we proceeded. " –Stephen Slade, MD Supported by an unrestricted educational grant from Abbott Medical Optics Click to read and claim CME credit The news magazine of the American Society of Cataract & Refractive Surgery digital.eyeworld.org Supplement to EyeWorld Daily News, Sunday, May 8, 2016 The news magazine of the American Society of Cataract & Refractive Surgery digital.eyeworld.org Supplement to EyeWorld Daily News, Monday, May 9, 2016 Innovative IOL technologies for the cataract surgeon

• Cover